D Spectrum - Diabetes Care - Am Diabetes Assoc RESULTS—Administration of atorvastatin 10 and 80 mg resulted in significant
reductions (25 and 35%, respectively) of plasma triglyceride levels (both P <
0.001). The difference between 10 and 80 mg was not statistically ... Related articles
LA Jokubaitis, RH Knopp, J Frohlich - JOURNAL OF INTERNAL MEDICINE-OXFORD- …, 1994 - grande.nal.usda.gov Record Detail. Return to previous page, Save: Title: Efficacy and safety of fluvastatin
in hyperlipidaemic patients with non-insulin-dependent diabetes mellitus ... Cited by 9 - Related articles - Cached - BL Direct - All 3 versions
M Cassader, G Ruiu, R Gambino, N Alemanno … - Atherosclerosis, 1993 - ncbi.nlm.nih.gov 1: Atherosclerosis. 1993 Feb;99(1):47-53. Hypercholesterolemia in non-insulin-
dependent diabetes mellitus: different effect of simvastatin ... Cited by 11 - Related articles - All 2 versions
DW Erkelens - The American journal of cardiology, 2001 - Elsevier Patients with type 2 diabetes mellitus have an elevated risk of morbidity and
mortality from cardiovascular disease. This risk is partly attributable to an
increased prevalence of classic coronary artery disease risk factors and ... Cited by 56 - Related articles - BL Direct - All 7 versions
CM Hwu, CF Kwok, HS Chen, KC Shih, SH Lee … - Diabetic Medicine, 1999 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 16 - Related articles - BL Direct - All 4 versions
DG Orloff, MA Blazing, CM O'Connor - American Heart Journal, 1999 - Elsevier Patients with type 2 diabetes mellitus (non–insulin-dependent diabetes
[NIDDM]), have been underrepresented in large-scale, clinical end point trials
of lipid-altering drugs. These patients are at markedly increased ... Cited by 2 - Related articles - BL Direct - All 7 versions
AO Marcus - Postgraduate medicine, 2001 - ncbi.nlm.nih.gov Because patients with type 2 diabetes are at high risk for cardiovascular
events, lipid abnormalities in these patients should be aggressively and
efficiently treated. What is the rationale behind such an approach, and ... Cited by 14 - Related articles - BL Direct - All 8 versions
[CITATION] SELECTED POSTER PRESENTATIONS
R Inhibitor, N Function, IND Rats - Advanced Studies in Medicine Related articles
EOF ROSUVASTATIN, H ANew, R INHIBITOR … - asimstore.com Two well-known risk factors for diabetic vascu- lopathy and neuropathy are that
impaired blood flow is a major contributing factor to nerve dys- function in
diabetes and that endothelial abnormal- ities contribute to elevated lipid ... Related articles - All 4 versions
M Miller, A Dobs, Z Yuan, WP Battisti, H … - Current Medical Research and Opinion®, 2004 - informahealthcare.com 1University of Maryland Medical Center, Baltimore, MD, USA 2Johns Hopkins
University School of Medicine, Baltimore, MD, USA 3Merck & Co., Inc., West
Point, PA, USA ... Address for correspondence: Dr Joanne Palmisano, Merck ... Cited by 12 - Related articles - BL Direct - All 6 versions
